1. Phytochemicals: Potential Lead Molecules for MDR Reversal
   Boshra Tinoush et al, 2020, Frontiers in Pharmacology CrossRef
2. Strategies to enhance the response of liver cancer to pharmacological treatments
   Jose J. G. Marin et al, 2024, American Journal of Physiology-Cell Physiology CrossRef
3. Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells
   Yan Wen et al, 2017, Oncotarget CrossRef
4. Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: From bench to bedside
   Bing Hu, 2015, World Journal of Hepatology CrossRef
5. Camellia sinensis: Insights on its molecular mechanisms of action towards nutraceutical, anticancer potential and other therapeutic applications
   Priya Chaudhary et al, 2023, Arabian Journal of Chemistry CrossRef
6. The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases
   Sha Li et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
7. PEG-Derivatized Dual-Functional Nanomicelles for Improved Cancer Therapy
   Yanping Li et al, 2019, Frontiers in Pharmacology CrossRef
8. Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy
   José M. Estrela et al, 2017, Journal of Medicinal Chemistry CrossRef
9. The role of catechin in electroporation of pancreatic cancer cells – Effects on pore formation and multidrug resistance proteins
   Olga Michel et al, 2022, Bioelectrochemistry CrossRef
10. Active Tumor-Targeted co-Delivery of Epigallocatechin Gallate and Doxorubicin in Nanoparticles for Combination Gastric Cancer Therapy
    Fwu-Long Mi et al, 2018, ACS Biomaterials Science & Engineering CrossRef